Remaley; Alan T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Remaley; Alan T..The latest application filed is for "methods for assessing cardiovascular disease or inflammatory disease risk using non-exchangeable lipid probe".

Company Profile

1.9.15

Remaley; Alan T. - Bethesda MD
REMALEY; ALAN T. - BTHESDA MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Assessing Cardiovascular Disease Or Inflammatory Disease Risk Using Non-exchangeable Lipid Probe App 20220178953 - Remaley; Alan T. ; et al.	2022-06-09
Lipoprotein Targeting Protease Inhibitors And Uses App 20220168379 - Remaley; Alan T. ; et al.	2022-06-02
Lipoprotein Targeting Protease Inhibitors And Uses App 20200078434 - Remaley; Alan T. ; et al.	2020-03-12
Drug Delivery Vehicle App 20170333563 - Lacko; Andras G. ; et al.	2017-11-23
Lipoprotein Targeting Protease Inhibitors And Uses App 20170319643 - Remaley; Alan T. ; et al.	2017-11-09
Drug delivery vehicle Grant 9,314,532 - Lacko , et al. April 19, 2	2016-04-19
Drug Delivery Vehicle App 20150343069 - Lacko; Andras G. ; et al.	2015-12-03
Peptides promoting lipid efflux Grant 8,936,787 - Remaley , et al. January 20, 2	2015-01-20
Multi-domain amphipathic helical peptides and methods of their use Grant 8,835,378 - Remaley , et al. September 16, 2	2014-09-16
Chemical Modification Of Apolipoprotein Mimetic Peptides For The Production Of Therapeutic Agents App 20140213502 - Remaley; Alan T. ; et al.	2014-07-31
Drug Delivery Vehicle App 20140045950 - Lacko; Andras G. ; et al.	2014-02-13
Multi-domain Amphipathic Helical Peptides And Methods Of Their Use App 20120148642 - Remaley; Alan T. ; et al.	2012-06-14
Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides Grant 8,148,323 - Remaley , et al. April 3, 2	2012-04-03
Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3 Grant 8,071,746 - Remaley , et al. December 6, 2	2011-12-06
Peptides Promoting Lipid Efflux Via Abca1 And Activating A Lipoprotein Lipase App 20110033518 - Remaley; Alan T. ; et al.	2011-02-10
Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease App 20110034419 - Argraves; Kelley M. ; et al.	2011-02-10
Multi-domain Amphipathic Helical Peptides And Methods Of Their Use App 20100203099 - REMALEY; ALAN T. ; et al.	2010-08-12
Multi-domain Amphipathic Helical Peptides And Methods Of Their Use App 20090270331 - Remaley; Alan T. ; et al.	2009-10-29
Multi-domain amphipathic helical peptides and methods of their use Grant 7,572,771 - Remaley , et al. August 11, 2	2009-08-11
Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation App 20090011974 - Bocharov; Alexander V. ; et al.	2009-01-08
System and method for intelligent quality control of a process Grant 6,556,951 - Deleo , et al. April 29, 2	2003-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.